Search

Younger consumers, particularly Gen Z and Millennials, are increasingly choosing low-dose THC beverages over alcohol for social occasions to avoid hangovers and negative health effects, creating a significant opportunity for retailers. To capitalize on this "sober curious" shift, retailers should focus on education, marketing the party-ready, no-hangover value proposition, and promoting low-dose, sessionable options around holidays. < Back Cannabis Drinks vs. Booze for New Year’s Dec 30, 2025 Taylor Engle MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Something subtle but seismic is happening at the bar cart. Younger consumers are still going out, dressing up, and chasing that New Year’s sparkle — but increasingly, they’re skipping the booze. Instead of champagne flutes and cocktail shakers, low-dose THC spritzers and cannabis-infused seltzers are taking center stage, signaling a cultural shift retailers can no longer afford to ignore. *Time* data shows the share of adults younger than 35 who drink alcohol dropped from 72 percent in the early 2000s to about 62 percent now. Gen Z, in particular, is drinking roughly 20 percent less alcohol per capita than millennials did at the same age and spending far less on booze overall. For cannabis retailers and brands, that shift is a once-in-a-decade opportunity. Celebrating and socializing historically have belonged to champagne, spirits, and late-night bar tabs. Today, traditional beverages frequently are supplanted by low-dose THC spritzers, hemp seltzers, and other “sober curious” options that nevertheless feel elevated, social, and fun. The question for retailers is how to catch the wave. The sober-curious New Year celebration “For us, drinks hit the most during periods like Dry July or Sober October, where people are purposefully avoiding alcohol entirely,” said Flip Croft-Caderao, founder of infused beverage brand Cali Sober. “Thanksgiving and Christmas are big bumps for us too, but I think New Year’s and St. Paddy’s Day are the last holidays that are really built for drinking. Still, we’re seeing so many more people be sober-curious or totally sober from alcohol. This is my third New Year’s where I haven’t had a drink, and a lot of people are joining the movement.” What’s striking, Croft-Caderao added, is that many of those moving into cannabis beverages don’t have a dramatic rock-bottom story. They just choose to abstain. “I meet a lot of sober-curious people, and a lot of them don’t have these huge stories of transformation,” Croft-Caderao said. “They’re more paying attention to the key factors and side-effects negatively impacting them: weight gain, hangovers, physical and mental health. Alcohol makes a lot of people feel more anxious or depressed, so they’re turning to cannabis or mushrooms instead.” That mindset aligns with broader national trends. Nearly one in two Americans now say they’re trying to drink less. Public health researchers point to the “sober curious” movement and rituals like Dry January and Sober October as catalysts that helped push drinking rates among Americans to their lowest levels in decades. At the same time, the culture around how people socialize is evolving. Morning “wellness raves” like Daybreaker combine yoga, DJ sets, and meditation in alcohol-free settings. Coffee shops are doubling as cocktail bars, serving $10–15 espresso mocktails with nightclub aesthetics and zero hangovers. Daytime, caffeine-fueled “daylife” events are emerging as a global trend: electronic dance music in the front, green juice in the back. “Culture is the hardest thing to overcome. Alcohol is so ingrained in everything we do,” Croft-Caderao said. “And booze itself is a gnarly drug, and a hard one to quit. It’s having to get over the fact that your friends are like, ‘What’s wrong with you? Why aren’t you drinking?’ However, as we get older, I’m realizing younger generations are a lot more open to the idea of people not drinking, so those conversations are a lot easier to navigate.” For retailers, this change isn’t just a vibe shift. It’s a purchasing shift. What cannabis drink data says On the ground, cannabis beverages are still a small but meaningful slice of dispensary revenue, but they’re growing in power. “We’ve had a lot of success working with cannabis beverage companies, because they have a stronger blueprint coming from alcohol and other distribution data sources to enhance their sales,” said Vibhav Gupta of CannMenus, which tracks real-time dispensary menu data. “Around the holidays, you see an uptick in beverage sales, especially recently.” Within those fluctuating sales figures, one pattern is clear: “In dispensaries, the sales are very much concentrated to the 100mg segment,” Gupta said. “High-dose dominates most of states’ dispensary sales.” During the holidays, lower-dose brands take more of a front seat, but high-dose products still tend to rule the day. Gen Z and millennials: party-ready, not plastered “Consumers, especially Gen Z and millennials, are definitely the trending demographic that are most likely to substitute alcohol for cannabis drinks,” said Chase Dawson, digital marketing director at Mango Cannabis. “These younger generations were already drinking less than the older generations were at their age, but the legalization of cannabis and the diversity of products coming into the market really ushered in the age of cannabis drinks.” The value proposition is simple and powerful: same social signal, less collateral damage. “This is great news for cannabis retailers, because these consumers love the ‘party-ready’ feeling they get without the nasty hangover in the morning,” Dawson said. “They also don’t have the same detrimental long-term effects on the liver like alcohol, which is technically a toxin, can.” For retailers, that means marketing aimed at younger consumers should focus less on “drinks versus joints” and more on “how do you want to feel when you party?” Calm, social, present, and functional the next morning make a compelling sales story. Education is the secret weapon If there’s one non-negotiable for beverage success, it’s education. “The best tip for anyone getting into cannabis drinks, just like any edible, is to start at a low dose,” Dawson said. “This is a little harder to do with a drink than typical edibles, where dosing is typically based on how much you’ve eaten. So, just sip steady and monitor how your body’s feeling.” That simple “sip steady” mantra works on display cards as well as in staff talking points, email campaigns, and social content. Retailers should be crystal-clear about: - Onset times compared to edibles. - Differences between cannabis-derived THC, CBD, and hemp-derived beverages. - The differences in safe serving sizes for newcomers and experienced consumers. - How to substitute a cannabis drink for a glass of wine or cocktail in a 1:1 ritual The goal is not to scare people; it’s to help them feel in control of their experience. Celebrations can be emotionally loaded, and consumers want to feel a little care and comfort with their euphoria. How retailers can win So, what does all of this mean for operators? Here are a few tips for success with infused beverages. Build a dedicated beverage moment Create a small but focused “bar” in-store with cans, mixers, and plenty of low-dose options. Pair them visually with glassware, mocktail recipes, and party accessories. Lead with low-dose and sessionable Keep high-dose beverages in the mix for experienced customers, but build your storytelling around sessionable, 2–5mg products that feel familiar to social drinkers and sober-curious newcomers. Explicitly tie into sober-curious culture Use language that nods to Dry January, hangover-free mornings, and wellness-forward celebrations. Consumers are already there; you’re simply giving them the tools they need. Leverage data to time promotions Build promotions and inventory planning around Thanksgiving, Christmas, New Year’s Eve, and even St. Patrick’s Day, where alcohol historically has dominated. Now’s the chance to change that narrative. Train your team to have “How do you want to feel?” conversations Encourage staff to ask about desired mood and setting, then recommend beverages (and other formats) accordingly. You’re not just selling a drink; you’re architecting an evening. With the popularity of infused beverages rising, the future of celebration is looking a lot less boozy and a lot more plant-based. Retailers who understand that shift won’t just sell more beverages. They’ll cement their place in the next evolution celebratory gatherings. ------------------------------ Cannabis drinks vs. alcohol: what retailers should know 1. Are cannabis drinks replacing alcohol for younger consumers? Not entirely, but Gen Z and millennials are drinking less alcohol and increasingly choosing low-dose THC beverages for social occasions, especially holidays. 2. Why are cannabis drinks popular during New Year’s? They offer a celebratory, social experience without hangovers, next-day fatigue, or alcohol’s long-term health effects. 3. What THC dosage works best for new cannabis drink customers? Low-dose options (2–5mg THC) are best for newcomers, offering sessionable effects similar to a glass of wine or cocktail. 4. How should retailers educate customers about cannabis beverages? Staff should explain onset times, dosing, and how to “sip steady,” helping customers feel in control of their experience. 5. When do cannabis beverage sales peak? Sales often spike around Thanksgiving, Christmas, New Year’s Eve, and other alcohol-heavy holidays like St. Patrick’s Day. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Switzerland is on track to fully regulate adult-use cannabis. The proposed legislation will undergo public consultation and could be implemented as early as 2026. Key points include allowing adults to grow up to three plants, state-controlled retail sales, strict regulations, taxation based on THC content, cantonal oversight, and zero-tolerance policies for driving under the influence. < Back Switzerland Makes Moves to Legalize Adult-Use Cannabis Feb 22, 2025 Jamie Pearson Cannabis Now Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Following a landmark vote by the National Council’s Social Security and Health Committee (SGK-N) on February 14, 2025, Switzerland is on track to fully regulate adult-use cannabis. The committee approved a draft federal law by a vote of 14-9 (with 2 abstentions), paving the way for the legal cultivation, sale, possession and consumption of cannabis. The proposed legislation will undergo public consultation this summer, and if approved, could be implemented as early as 2026. “It was undisputed in the Commission that the use of cannabis is a social reality. The majority of the Commission considers the current situation to be unsatisfactory and the prohibitive approach to be flawed,” states a press release from the Commission. “The past year in Europe has been encouraging for homegrowers and the regulated cannabis industry as a whole, even more so as Switzerland looks to expand access to the plant,” said Shai Ramsahai, president of European-based Royal Queen Seeds, the world’s largest cannabis seed bank. *Key Provisions of the Proposed Law* The new cannabis law builds on Switzerland’s existing adult-use cannabis pilot projects, which have been operating in cities like Basel, Zurich and Bern since 2023. These programs have tested controlled sales in dispensaries, pharmacies and social clubs, providing data on the impact of regulated cannabis access. Here are the primary points of the proposed law: 1. *Personal Cultivation:* Adults aged 18 and over would be allowed to grow up to three female cannabis plants for personal use. 2. *Commercial Sales:* Cannabis production would be profit-oriented, but retail sales would operate under a state-controlled license system (monopoly). The sale in retail locations must not be profit oriented. Potential profits from sales would be reinvested into prevention, harm reduction and addiction support programs. 3. *Strict Regulation:* Cannabis products must be sold in neutral packaging with health warnings and will be subject to a complete advertising ban. The entire supply chain would be digitally tracked to ensure compliance. 4. *Taxation & Revenue Use:* Products will be taxed based on THC content and consumption method, with revenues redistributed through the health insurance system. 5. *Cantonal Oversight:* Switzerland’s cantons (similar to US states) will have significant control over local licensing and enforcement. 6. *Road Safety:* Zero-tolerance policies for driving under the influence of cannabis will remain in place. Anyone caught with THC in their system will be considered unfit to drive. *Cannabis Leaders Weigh In* “Switzerland’s model balances state control, personal autonomy with home cultivation and tax redistribution for harm reduction, reinforcing a responsible, public health approach,” Ramsahai said. “At Royal Queen Seeds, we support policies that empower individuals and create structured opportunities for businesses to contribute to a responsible and flourishing industry.” Live from the February 21, 2022 Talman House Event in Zürich, Switzerland, three other experts in cannabis provided their insights on the draft legislation. Paul-Lukas Good, a renowned Swiss attorney and President of Swiss Cannabis Research, a nonprofit association that organizes adult-use cannabis pilot trials, emphasized the significance of this legislative step. “This draft law represents a major shift in Swiss drug policy. It acknowledges the failure of prohibition and aims to create a transparent and responsible market that prioritizes public health.” Andrew David Petronanos, CEO & Chairman of Zürich-based Dascoli Pharma AG added that “Switzerland’s proposed adult-use legalization rules demonstrate how a state-controlled cannabis model can ensure strict regulation designed to prevent misuse, while preserving pharmaceutical integrity. This approach could guide the EU legalization model, keeping medical and adult-use markets distinct for safety and compliance.” Bob Hoban, global cannabis industry veteran says, “A legal cannabis market in Switzerland will drive innovation, create jobs and generate significant tax revenue.” As a faculty member of the Cannabis Policy Institute at the University of Nevada, Las Vegas (UNLV), Hoban is leading a research project to determine the factors that can objectively determine the “success” of any given cannabis legalization program. To that end, Hoban notes that the Swiss regulatory program “ensures quality control and consumer safety while extinguishing the illicit market. And this sets the program up for demonstrable success that both the industry and the international community require.” Sergio Martinez Bejar of Barcelona and New York-based Blimburn Seeds, reflected on Switzerland’s proposal to allow three plants per person for home cultivation. “A policy like this creates an opportunity for seed companies to engage directly with consumers while ensuring genetic diversity and quality control. It encourages home growing and also challenges us to innovate and adapt to a sophisticated and regulated Swiss market.” With growing public and industry support, Switzerland’s move toward adult-use legalization could help more countries across Europe adopt similar cannabis policies. The final version of the law will be shaped by public consultation in the coming months, and the momentum toward conservative legalization appears stronger than ever. The post Switzerland Makes Moves to Legalize Adult-Use Cannabis appeared first on Cannabis Now. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Including the Depp South's biggest medical shop. The post America’s cannabis dispensary grand openings for January 2025 appeared first on Leafly. < Back America’s cannabis dispensary grand openings for January 2025 Jan 3, 2025 Zack Ruskin Leafly Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Including the Depp South's biggest medical shop. The post America’s cannabis dispensary grand openings for January 2025 appeared first on Leafly. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

A Florida court ruled that tens of thousands of signatures for an adult-use cannabis legalization campaign can be discarded, and arrests of campaign workers by state law enforcement continue, dealing a significant setback to the initiative. < Back Florida cannabis legalization campaign dealt setback as arrests continue Jan 26, 2026 Chris Roberts MJbizDaily Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A Florida court ruled that tens of thousands of signatures submitted by an adult-use cannabis legalization campaign can be thrown out. Meanwhile, state law enforcement continues to arrest campaign workers. Florida cannabis legalization campaign dealt setback as arrests continue is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Kentucky hemp farmers are urging Senator Mitch McConnell to abandon his efforts to recriminalize some hemp products, warning of "catastrophic consequences" for their farms and livelihoods. McConnell, who championed the 2018 Farm Bill legalizing hemp, now seeks to ban hemp derivatives with "quantifiable" THC, claiming he never intended to allow intoxicating cannabis products. Farmers argue this would destroy their market and empower the illicit market, advocating instead for responsible regulation like age restrictions and uniform testing. Senator Rand Paul (R-KY) has worked to remove the ban from legislation and is pushing for a bill to triple the legal THC concentration in hemp. The U.S. Hemp Roundtable and an alcohol industry association also oppose the ban, while some GOP lawmakers and a beer industry group express concerns about unregulated hemp products. < Back Farmers Tell Mitch McConnell His Push To Ban Hemp Products With THC Will Cause ‘Catastrophic Consequences’ Sep 25, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Dozens of hemp farmers from Kentucky are urging their state’s senior U.S. senator to back off from his push to recriminalize some products that are derived from their crops. Sen. Mitch McConnell (R-KY), who successfully championed the federal legalization of hemp through the 2018 Farm Bill, has been working this year to roll back that policy by prohibiting hemp derivatives with a “quantifiable” amount of THC, saying that he never intended to allow a market for intoxicating cannabis products. The recriminalization proposal has advanced in both the House and Senate this session, though a push by McConnell’s home state colleague, Sen. Rand Paul (R-KY), got the provision removed from their chamber’s bill ahead of its final passage. Paul has cautioned, however, that prohibitionist forces are working to include the ban in other legislative vehicles—which he said could potentially be enacted within weeks. “If Congress moves to eliminate the end markets that make our crop viable, we will suffer immediate and catastrophic consequences,” the 58 farmers who have agreements to sell hemp crops they have harvested this season wrote to McConnell in the new letter on Monday. “We have taken out loans, hired the necessary help, planted the crop, and contracted with processors and/or brands. Any legislative change that pulls the rug out from under this market—especially mid-season—is a direct blow to our farms, families, and rural communities.” The farmers, who are requesting an in-person meeting with McConnell, wrote that “hemp is the foundation of our diversified, sustainable farm operations that helps us weather tough commodity cycles, diversify away from tobacco and empower profit in an uncertain economy”—adding that its federal legalization in 2018 gave them a new crop with “real economic opportunity” for the “first time in decades.” While the letter signatories do not support a ban along the lines of what McConnell has pushed in Congress this year—which they say would “empower the illicit market and destroy American farm income in the process”—they do back “responsible regulation” for the crop. “We support age restrictions along with uniform testing, labeling and packaging requirements, all of which are reflected in Kentucky’s award-winning laws and regulations. But outright prohibition is not the answer, and it will not make anyone safer,” they wrote. “We are proud of what we grow. We are proud to be building a domestic supply chain for an American crop which is catalyzed by the cannabinoid market. At this time we are asking you, respectfully but firmly: Do not criminalize our harvest. Protect our farms. Keep Kentucky’s hemp market legal, safe, and effective. Let us prove once again that Kentucky leadership is the answer to bad actors and unsafe products by enforcing and enriching the robust regulations that have set Kentucky apart and ahead of all others.” Jonathan Miller, general counsel at the U.S. Hemp Roundtable, told Marijuana Moment on Wednesday that the organization is “grateful to these hard working farmers for speaking truth to power.” “The current language would wipe out hemp cannabinoid farming in Kentucky, which encompasses 87 percent of all hemp grown in the state,” he said. “We are very hopeful that Senator McConnell will listen to these farmers—who are relying on the language he inserted in the 2018 Farm Bill for their livelihoods.” Paul, for his part, recently cautioned that the cannabis policy movement has “swung hard on the prohibitionist side” amid the ongoing debate over intoxicating hemp products. And he worries that, if things go awry, the hemp market could be decimated “within the next two weeks.” Asked about recent conversations with McConnell and Rep. Andy Harris (R-MD), a prohibitionist championing a hemp ban on the House side, Paul said “we’ve been working diligently” with the staff “trying to reach a compromise.” “A lot of the conversations have been constructive. They say, at least on the surface, they’re not trying to eliminate it—but I think we are, in some ways, talking past each other,” he said. Meanwhile, Paul recently filed a standalone bill that would go in the opposite direction of the hemp ban, proposing to triple the concentration of THC that the crop could legally contain, while addressing multiple other concerns the industry has expressed about federal regulations. The senator introduced the legislation, titled the Hemp Economic Mobilization Plan (HEMP) Act, in June. It mirrors versions he’s sponsored over the last several sessions. Harris, who championed the hemp THC ban in his chamber version of the agriculture spending legislation, told Marijuana Moment that he wasn’t concerned about any potential opposition to the hemp ban in the Senate—and he also disputed reports about the scope of what his legislation would do to the industry. The Congressional Research Service (CRS) released a report in June stating that the legislation would “effectively” prohibit hemp-derived cannabinoid products. Initially it said that such a ban would prevent the sale of CBD as well, but the CRS report was updated to exclude that language for reasons that are unclear. The hemp language is largely consistent with appropriations and agriculture legislation that was introduced, but not ultimately enacted, under the last Congress. Hemp industry stakeholders rallied against that proposal, an earlier version of which was also included in the base bill from the subcommittee last year. It’s virtually identical to a provision of the 2024 Farm Bill that was attached by a separate committee last May via an amendment from Rep. Mary Miller (R-IL), which was also not enacted into law. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* A leading alcohol industry association, meanwhile, has called on Congress to dial back language in the House spending bill that would ban most consumable hemp products, instead proposing to maintain the legalization of naturally derived cannabinoids from the crop and only prohibit synthetic items. Wine & Spirits Wholesalers of America (WSWA) President and CEO Francis Creighton said in a press release that “proponents and opponents alike have agreed that this language amounts to a ban.” Separately, key GOP congressional lawmakers—including one member who supports marijuana legalization—don’t seem especially concerned about provisions in the bill despite concern from stakeholders that it would put much of the hemp industry in jeopardy by banning most consumable products derived from the plant. A report from Bloomberg Intelligence (BI) last year called cannabis a “significant threat” to the alcohol industry, citing survey data that suggests more people are using cannabis as a substitute for alcoholic beverages such a beer and wine. Last November, meanwhile, a beer industry trade group put out a statement of guiding principles to address what it called “the proliferation of largely unregulated intoxicating hemp and cannabis products,” warning of risks to consumers and communities resulting from THC consumption. *Read the hemp farmers’ full letter to McConnell below:* The post Farmers Tell Mitch McConnell His Push To Ban Hemp Products With THC Will Cause ‘Catastrophic Consequences’ appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Colorado cannabis regulators announced one of the largest marijuana product recalls in the state's history, which affected a record number of retailers in 2025. < Back Colorado cannabis recalls affect record number of retailers in 2025 Sep 30, 2025 Margaret Jackson MJbizDaily Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Colorado cannabis regulators announced one of the largest marijuana product recalls in the state’s history. Colorado cannabis recalls affect record number of retailers in 2025 is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Cannabis packaging is evolving beyond simple product protection to become a crucial branding tool that conveys values, connects with consumers emotionally, and helps destigmatize cannabis. Modern packaging emphasizes sleek design, sustainability, and storytelling, moving away from outdated tropes to align with wellness and lifestyle. This "stealth activism" through design normalizes cannabis as part of everyday life, building trust and appealing to a wider consumer base, especially Gen Z and the canna-curious. Brands that prioritize thoughtful design, sustainability, and emotional connection in their packaging are finding a significant advantage in the competitive cannabis market. < Back Packaging: the Trojan Horse of Cannabis Branding Jul 9, 2025 Taylor Engle MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Cannabis packaging performs many functions. In addition to protecting products, packaging must clearly identify what’s inside, satisfy regulatory requirements, and convey information about safe storage and use. Packaging also provides opportunities — chief among them, the opportunity to leave a lasting impression on consumers, many of whom now prefer products that fit seamlessly within their lives. Whether it’s a compostable container that aligns with their sustainability focus, a minimalist label that blends into their nightstand aesthetic, or a box that elevates the ritual of consumption itself, packaging has become a strong emotional touchpoint for consumers, and brands are listening. [image: Angela-Pih-Point-Brand]Angela Pih, founder, Point Brand. (Photo: Point Brand) From wellness-inspired elegance to stealth activism disguised as countertop chic, cannabis brands are rejecting tired stoner tropes in favor of something more refined, and in turn, more real. According to Angela Pih, founder of strategic marketing firm Point Brand, “There’s still a market for the stoner-bro vibe, but when we think about how to grow the industry, it’s about how cannabis fits seamlessly into your everyday lifestyle.” In an oversaturated market, the loudest voice doesn’t always win. Instead, consumers are gravitating toward clearer, cleaner, and more considered. That’s why a new wave of creators is elevating packaging into a storytelling medium that reflects identity, values, and a deeply personal connection to the plant. Packaging as experience At CAKE She Hits Different, packaging is far more than a product container. Co-founder and Chief Executive Officer Chloe Kaleiokalani considers the exterior trappings the start of the experience. She creates packaging that invites customers into a visually rich, emotionally resonant world. From vibrant colors to playful, space-inspired graphics, CAKE’s branding is crafted to feel cohesive, intentional, and alive. “I tend to be obsessive about designing a cohesive, high-end look, where every color, format, and artwork is meticulously chosen,” Kaleiokalani said. “For me, packaging is so much more than a container; it’s a statement that sets the tone for the entire CAKE experience. And I want that statement to spark joy, curiosity, even a little thrill before our customers touch the product, making the act of opening a CAKE product feel special, like a moment of connection to something vibrant, premium, and uniquely us. “Then, some people rip open our boxes like godzilla in Tokyo, and that’s cool too,” she added. This is design as storytelling: immersive, premium, and unmistakably associated with the brand. CAKE’s visual identity is unapologetically feminine, boldly setting products apart in an industry overrun with masculine cues. Rather than catering to the masses, CAKE embraces a strategy of magnetic authenticity, and the result is an instantly recognizable packaging experience. The brand relentlessly pursues a goal of emotional resonance, and in an industry often devoted to the status quo, this is a strong differentiator. [image: CAKE-She-Hits-Different-Designer Rosin-cannabis-vapes] Lessons from CPG Cannabis stigma may not be entirely dead, but it’s on its last legs. Today’s consumers don’t hide their products anymore. Instead, they want cannabis displayed, integrated, and celebrated. So, taking cues from skincare, supplements, and craft beverages, consumers gravitate toward cannabis products that feel like they belong out in the open. Brands that embrace the design standards of high-end consumer packaged goods (CPG) are finding a powerful edge. Well-designed packaging doesn’t just look good; it also communicates quality and care. A brand’s packaging is its ambassador, reflecting the thought put into the product within and subtly reinforcing consumer trust before they’ve even cracked the seal. “Packaging is part of the marketing mix, especially in cannabis,” said Pih, who has led CPG strategies across industries from cosmetics to cannabis. “Today’s consumers aren’t choosing brands with packaging that looks like weed. Cannabis is a functional plant that can help you live a more vibrant life, so I don’t think to myself, ‘How do I brand a product for weed?’ I think about branding another piece of your wellness routine — something that looks like everything else you pick up at Target for your medicine cabinet or nightstand.” Her work with companies like Autumn Brands, Papa & Barkley, and Loud+Clear demonstrates this lifestyle-driven, wellness-integrated approach resonates not only with longtime consumers but with the canna-curious, too. “Gem + Jane, which is created by an all-women team, is another powerful example of packaging that stands out really well at the dispensary,” Pih said. “When you’re drinking a can at brunch, it doesn’t scream ‘weed.’ That’s sort of my stealth activism in creating and building brands within our space, because as we think about destigmatizing, then cannabis should really fit into everything else. Packaging design is a major part of the arsenal.” [image: Loud-and-Clear-vape-cartridges]Photo: Point Brand Stealth activism This is what Pih means by “stealth activism”: branding cannabis like it has always belonged. It’s the Trojan horse effect — pulling people in with beauty, intention, and familiarity, then showing them how cannabis should always have been part of the everyday wellness equation. Pih doesn’t suggest hiding the plant or being deceitful but instead normalizing products through design, storytelling, and thoughtful placement as a means of elevating cannabis from taboo to trusted. For brands targeting Gen Z and canna-curious consumers, education and aesthetic must go hand-in-hand. Those two demographics, in particular, want a lifestyle they recognize, values they align with, and information that empowers their choices. And when the ritual of consumption is presented with care — from how the box opens to the weight of the bottle to the design of the label — that ritual becomes a moment, a statement, and a story. “When you walk into a dispensary, you’re faced with a plethora of products, and you don’t know which is credible or which is just there,” Pih said. “That being said, I’ve heard a lot of consumers gravitate toward brands they respect — that look intentional in what they do. “And when you think about the top three reasons consumers turn to cannabis — sleep, anxiety, and pain — well, that’s all part of living well,” she continued. “I see it less as medical-versus-recreational and more ‘does it help you feel better? Does it help you chill out and have fun? Does it help you connect with other people because you’re less anxious and more at peace?’ Try to think about it from the context of who your consumer is and what they’re looking to solve when they’re shopping. Then, you can position your brand as one that really understands them and their needs.” [image: Gem-and-Jane-cannabis-drinks-lineup]Photo: Point Brand Sustainable sells Sustainability is a core pillar for many cannabis brands. HoneyProjects CEO Jeffrey Miller understands why. “In New Jersey, we’re seeing sustainability and values-based choices gain traction with customers,” he said. “People are starting to ask about recyclable packaging and are drawn to compelling stories around environmentally sensitive practices. Production methods like living soil and organic cultivation are taking root at the product level, with sustainable packaging close behind. We believe the next chapter of cannabis in New Jersey will see deeper engagement with brands that tell authentic, values-driven stories that not only resonate with customers but also elevate the quality of their cannabis experience in meaningful ways.” In a market that’s still defining itself, details like sustainability from seed to after-sale matter. “It can be incredibly challenging to achieve sustainability in the cannabis vape market due to the strict [California Department of Cannabis Control] regulations, but we don’t let that stop us from taking steps in the right direction,” CAKE’s Kaleiokalani said. “We’re proud to be making meaningful moves. Our updated Designer Distillate packaging decreased paper use by about 70 percent and decreased plastic use by about 50 percent. Other initiatives we’re pursuing include developing recycling programs that work within state regulations, exploring innovative sustainable materials, and expanding product lines that naturally require less packaging, like flower.” Story-first merchandising At HoneyProjects, shelf impact and emotional connection are inseparable, and the brand philosophy centers on connecting independent producers who care deeply about their craft with consumers discovering how that impacts the consumer experience. “We often introduce smaller brands without big marketing budgets or widespread recognition, which adds responsibility to how we curate our shelves, screens, and spaces,” Miller said. “That way, we create visual and physical merchandising that tells stories. We’re committed to evolving storytelling content, positioning merchandising in harmony with brand narratives to help these brands build passionate communities and advocates, even on modest budgets.” A portal to the brand [image: Autumn-Brands-Nourishing-Muscle-and-Joint-Salve] In many ways, packaging has become a portal: a tactile invitation into a brand’s world and a reflection of the energy behind the product. Whether reflecting sleek minimalism, radiant femininity, or earth-first materials, great design makes consumers feel seen, inspired, and connected. “People are craving fresh energy in the cannabis space — something soulful, intentional, and infused with a feminine touch,” Kaleiokalani said. “Up until now, the industry has been dominated by a masculine aesthetic. CAKE is the antidote. I believe we are delivering the right vibe at the right time, and I feel that is a major factor in CAKE’s success.” For all the innovation happening in cultivation and formulation, it’s often the packaging that sparks trust. As unboxing culture continues to thrive, so does the importance of creating a moment, not just a product. Today’s cannabis consumers are curating their lives with intention: seeking brands that echo their values, elevate their rituals, and bring a little beauty to the everyday. Now is the moment for cannabis brands to view packaging not as a cost center, but as a creative opportunity — a vehicle for storytelling, sustainability, and soul. When done well, packaging becomes a quiet form of advocacy for the plant, the planet, and the people who experience cannabis with purpose. ------------------------------ Unboxing the Big Questions *Today’s cannabis packaging does a lot more than hold product. Here’s what’s driving the shift — and why it matters.* 1. *Why is cannabis packaging important for brands?* Cannabis packaging is more than just protection. It’s also a key branding tool that helps companies stand out, convey values, and connect emotionally with consumers. 2. *How is cannabis packaging evolving?* Modern cannabis packaging focuses on sleek design, sustainability, and storytelling. Brands are moving away from outdated stoner tropes in favor of aesthetics that align with wellness, lifestyle, and trust. 3. *What role does packaging play in cannabis marketing?* Packaging is a silent brand ambassador. It communicates quality, builds credibility, and shapes first impressions — often before a consumer even tries the product. 4. *Why is sustainability important in cannabis packaging?* Consumers increasingly prioritize eco-conscious choices. Brands using recyclable materials and minimal packaging can appeal to environmentally aware shoppers and differentiate in a competitive market. 5. *How are cannabis brands using design to reduce stigma?* Many brands adopt minimalist or wellness-inspired packaging that blends in with everyday products. This “stealth activism” approach helps normalize cannabis as part of a modern, healthy lifestyle. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Despite advanced delivery methods, many cannabis beverages underperform because they prioritize pharmaceutical efficacy over crucial beverage formulation elements like flavor, mouthfeel, and stability, leading to poor consumer retention. Successful brands must adopt the flavor chemistry and preservation best practices from the conventional beverage industry, as reliable taste is the key to repeat consumption in a category that competes with all other enjoyable beverages. < Back The Hidden Science Behind Successful Cannabis Beverages Jan 5, 2026 James Stephens MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Cannabis beverage data is compelling. Analysts regularly point to alcohol substitution, faster onset formats, and expanding consumer acceptance. Capital is flowing in, large operators are launching drink lines, and every trade show seems to feature a new formulation promising better bioavailability and quicker effects. And yet, many of these products quietly underperform. Not because the science of delivery is wrong. Nanoemulsions work. Onset claims are often real. Stability can be achieved. The issue shows up somewhere else: the moment a consumer takes a sip and decides whether the taste is something they want to experience again. Why cannabis beverages underperform despite advanced delivery Anyone who has worked in conventional beverages recognizes this immediately. Liquids are unforgiving. There is no chew time, no fat matrix, no flavor delay. Aroma, bitterness, sweetness, and mouthfeel arrive all at once, and the product is judged instantly. This isn’t unique to cannabis; it’s a reality of beverage formulation. Cannabinoids bring familiar challenges to that format. They are bitter, oil-based, and sensitive to time and temperature. Those traits are not unusual. Caffeine, botanical extracts, vitamins, and countless nutraceutical ingredients behave the same way. The food-and-beverage industry has spent decades learning how to work with the challenges. Flavor is the real moment of truth [image: Close-up of carbonated bubbles in a laboratory beaker with a scientific pH probe, illustrating beverage flavor analysis.]Precision analysis of carbonation and pH balance is essential for ensuring a consistent consumer experience in every sip. (Image: mg Creative) What’s interesting is how often cannabis beverages borrow their technical playbook from pharmaceutical delivery rather than from beverage formulation. Pharmaceutical systems optimize for efficacy, with the goal of getting an active compound into the bloodstream quickly and efficiently. Beverage systems optimize for repeat consumption by making something people actually enjoy drinking. Cannabis beverages need both approaches, but many teams come from cultivation, extraction, or compliance backgrounds, not from flavor chemistry or beverage research and development. The result is a category full of drinks that deliver cannabinoids effectively but struggle to feel complete as beverages. This helps explain why certain flavor profiles appear again and again. Citrus-, berry-, ginger-, and cream-forward profiles are not trends so much as reliable tools. They carry aroma well, tolerate acidity, and integrate bitterness more gracefully than many alternatives. For example, citrus and ginger profiles are particularly effective at aiding terpene retention in beverages while masking off-notes. Used well, they allow the underlying formulation to disappear into the experience. Used poorly, they simply mask problems. Bitterness, sweetness, and mouthfeel aren’t optional Sweetness is a good example. Sugar historically did far more than make beverages taste sweet. It also added body, softened bitterness, and shaped how flavor unfolded on the palate. When sugar is reduced or removed for calorie content, positioning, or regulatory reasons, those functions must be replaced. If they aren’t, the drink feels thin, harsh, or unfinished, regardless of potency. Mouthfeel plays a similar role. Carbonation bite, viscosity, and finish influence how quality is perceived and how flavors register. A thin beverage amplifies bitterness; a well-structured one moderates it. Consumers rarely describe this explicitly, but their purchasing behavior reflects their perception. Preservation and stability shape consumer trust Preservation introduces another quiet failure point. Cannabis beverages often sit in a difficult middle ground: nutritionally rich enough to support microbial growth, not always acidic enough to self-preserve, and filled with compounds that oxidize over time. Without thoughtful preservation strategies that combine pH control, antioxidants, appropriate packaging, and sometimes mild preservatives, products lose potency, develop “off” flavors, or destabilize long before they reach consistent retail velocity. None of these challenges are novel. The flavor and beverage industries have addressed them for decades through techniques like bitterness modulation, encapsulation timing, textural engineering, and multi-hurdle preservation. The knowledge exists; it simply lives outside the cannabis echo chamber. Beverage science already solved these problems The cannabis beverages that perform best reflect beverage industry best practices, even if they do so unintentionally. Their taste is stable warm and cold. They finish cleanly. They don’t rely on extreme sweetness to get through the first sip. And, most importantly, people actually finish an entire serving. As the category matures, novelty will matter less than reliability. Cannabis drinks aren’t competing only with other cannabis products. They’re also competing with every other beverage consumers already enjoy. The brands that recognize that fact early tend to build quieter, more durable momentum. In beverages, chemistry gets a product to market. Flavor keeps it there. ------------------------------ Cannabis beverage flavor science: your questions, answered 1. Why do many cannabis beverages fail despite fast onset? Many fail because high-tech delivery doesn’t compensate for a poor drinking experience. Consumer retention depends on flavor, mouthfeel, and stability — not just potency. 2. What makes cannabis beverages harder to formulate than edibles? Liquids deliver aroma, taste, and texture instantly, leaving no buffer for bitterness or imbalance. Unlike edibles, beverages are judged immediately on flavor and mouthfeel. 3. Why is bitterness such a challenge in cannabis drinks? Because cannabinoids are naturally bitter, oil-based compounds. Success requires advanced bitterness masking and flavor modulation to ensure the consumer only tastes the intended profile. 4. How does mouthfeel affect cannabis beverage quality? Mouthfeel influences how bitterness is perceived and how “complete” a beverage feels. Thin drinks amplify harshness, while structured textures improve flavor integration. 5. What can cannabis brands learn from the beverage industry? The beverage industry has decades of experience managing bitterness, sweetness, stability, and shelf life — knowledge that cannabis brands can apply directly to improve repeat sales. 6. What are the biggest cannabis beverage consumer trends for 2026? The most significant trend is the “sober-curious” shift, where consumers swap alcohol for low-dose, fast-acting THC seltzers that offer a social buzz without the hangover. Additionally, there is a surge in demand for “functional” beverages that pair cannabinoids with adaptogens like ashwagandha or L-theanine for targeted wellness effects like stress relief and focus. ------------------------------ [image: James Stephens Sinful Brands] Flavor chemist and microbiologist James Stephens is co-founder of Sinful, a cannabis beverage platform focused on translating modern food and beverage science into repeatable, scalable THC experiences. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The Appellate Court of Maryland ruled that delta-8 and delta-10 THC are illegal in the state, despite lax enforcement. While Maryland has a regulated adult-use industry for delta-9 THC, the court determined that synthesized hemp products containing delta-8 and delta-10 THC are not covered by the legalization program. This decision came after the Maryland Hemp Coalition argued that the state’s cannabis regulations created an unconstitutional monopoly. Separately, Maryland collected $18.4 million in cannabis industry tax revenue from April to June 2025. < Back Maryland Court Rules Delta-8 and Delta-10 THC Products Are Illegal Sep 15, 2025 Graham Abbott Ganjapreneur Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link [image: Law books & justice symbol] The Appellate Court of Maryland ruled last week that delta-8 and delta-10 THC are illegal and have “always been illegal” in the state, although their “prohibition has been the subject of lax enforcement,” the Baltimore Sun reports. Maryland has a regulated adult-use industry offering legal access to delta-9 THC, which occurs naturally in large quantities in cannabis and in very small quantities in hemp — which, according to federal law, must contain less than 0.3% THC content. Delta-8 and delta-10 THC, meanwhile, are typically synthesized from other cannabinoids harvested from industrial hemp, which is federally legal. In June, the Maryland Hemp Coalition, a nonprofit hemp industry association, argued in a lawsuit filed under federal law that the state’s cannabis regulations constitute an unconstitutional monopoly that unfairly punishes unlicensed hemp businesses out of the market. But the court determined that because hemp products utilize cannabinoids that must be synthesized and don’t appear naturally in significant amounts, the intoxicants are not covered by the legalization program. “The ability to engage in the broader cannabis market generally and the limited hemp-derived psychoactive products market specifically is not a matter of common right … the Cannabis Reform Act is reasonably required for protecting public interest.” — Appellate Court Judge Dan Friedman, in the opinion, via the Sun Meanwhile, Maryland collected $18.4 million in cannabis industry tax revenue from April to June 2025, according to the latest quarterly report. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The Cannabis industry is on the cusp of a monumental shift with the potential rescheduling of Cannabis from Schedule I to Schedule III. This shift could unleash growth, investment, and opportunity, but it also means a new ballgame for accounting and tax. The benefits of rescheduling include increased participation from banks, access to capital markets, and interstate commerce. However, challenges will remain, including compliance and regulatory complexities. Accountants and financial professionals will play a critical role in this new landscape. Investors will expect solid financial controls, compliance with regulations, and clear growth strategies. The elimination of 280E could have a massive impact on valuations. The regulatory landscape will be complex, with continued state-level regulations and increased federal involvement. Accountants will need to stay updated with rapidly changing regulations. < Back Rescheduling Cannabis: How It Will Shake Up Accounting & Tax Jun 15, 2024 Dope CFO Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Cannabis industry is on the cusp of a monumental shift that's about to rock the accounting and tax world. As a CPA with nearly a decade of experience in this niche, I've watched this industry explode from the ground up. We've gone from zero to a $33 billion legal market in 2023, with support for legalization at an all-time high. But hold onto your calculators, folks – what's coming next is going to make the past few years look like a warm-up lap. In April 2024, the DEA dropped a bombshell: they're considering rescheduling Cannabis from Schedule I to Schedule III. This isn't just another regulatory tweak; it's a seismic shift that could unleash a tidal wave of growth, investment, and opportunity. But it also means a whole new ballgame for accounting and tax in the Cannabis world. In this guide, we will provide an overview of how Cannabis rescheduling will impact accounting and tax, including: - The impact Cannabis rescheduling will have on valuations - How accounting and tax will change when Cannabis is rescheduled - What Cannabis accountants can do to prepare for Cannabis rescheduling - How Cannabis accountants can provide added value in the changing landscape If you're an accountant, investor, or Cannabis business owner, you need to be ready for what's coming. In this guide, I'm going to break down exactly how this rescheduling could shake up the industry, what it means for your bottom line, and how you can position yourself to ride this green wave to success. Let's dive in. *How Likely Is Cannabis Rescheduling?* One of the first questions we always get is, “how likely is Cannabis rescheduling or legalization?” People worry there is still a social stigma attached to marijuana and that it will impact not only the potential for rescheduling and legalization but also their potential for success in the Cannabis industry. According to an article published by Bloomberg, attitudes on Cannabis have shifted significantly in the last 50-60 years. Nearly 70% of all American adults now support full legalization. That is up from around 10% in 1969. (Source: Gallup) There is also bipartisan support for Cannabis legalization. Both red states and blue states support Cannabis legalization. For example, Cannabis is fully legal in Oklahoma, a traditionally red state, and Oregon, a historically blue state. (Source: mjbizdaily.com) You can poll any group you want - Republicans, Democrats, Independents - and you’ll find that a majority of adults support legalization. We have many examples of this across the United States. 24 out of 50 states now have full Cannabis legalization; we’ve seen that go from 0 to 24 in 10 years, and we expect that number to rise as we get closer to the 2024 election. All of that is to say, the industry and attitudes are changing. It will most likely begin with the DEA approving the rescheduling of Cannabis. Let’s look at what that means. *Understanding the Controlled Substances Act* The Controlled Substances Act established a federal drug policy that regulates the manufacture, importation, possession, use, and distribution of certain substances. The legislation created five schedules, or classifications, along with qualifications for a substance to be included in each. We’ll focus on Schedule 1, where Cannabis is currently scheduled, and Schedule III, the new proposed schedule for Cannabis. Schedule I is the highest and harshest schedule for a substance under the act. For a substance to be classified as Schedule I, it is said to have no medical use and high potential for both abuse and addiction. Other examples of substances classified as Schedule I include ecstasy, methamphetamine, heroin, and LSD. Something to note is that even drugs like fentanyl and oxycodone, which are responsible for tens of thousands of deaths annually, currently fall under Schedule II. Schedule III, the new proposed classification for Cannabis, is much milder. The substances in this classification have medical uses and while they still possess the potential for abuse and addiction, the risk is much lower. Other examples of substances in this classification include Tylenol, codeine, testosterone, and ketamine. Some of these are available over the counter while others are regularly prescribed by doctors. The DEA has recommended that Cannabis be moved from Schedule I to Schedule III. The reclassification would lead to a cascade of state and federal-level changes, and will completely change the market. *The Rescheduling Process* In October 2022, the Biden Administration launched an investigation into Cannabis being on Schedule I. The Health and Human Services (HHS) department recommended Cannabis be moved to Schedule III, and the FDA agreed. Now rescheduling is awaiting approval from the DEA. We’re cautiously optimistic as the DEA typically follows the recommendations from the HHS department. For now, things are looking green for the prospect of rescheduling at the very least. The Biden Administration is doing everything it can to gather votes and many industry experts, including us here at DOPE CFO, believe rescheduling will happen sooner rather than later. Let’s look at the benefits of rescheduling as well as some of the potential challenges that could arise. *Benefits and Challenges of Rescheduling* There are benefits and challenges that will come from rescheduling, We’ll start with the benefits. *Banking: from cash-only to full financial integration* The current banking situation for Cannabis businesses is, to put it mildly, challenging. Due to federal prohibition, most traditional banks have shied away from serving Cannabis clients, fearing potential legal repercussions. This has created a host of issues that have hampered the industry's growth and operational efficiency. Currently, many Cannabis businesses operate primarily in cash, which presents significant security risks and operational headaches. Imagine trying to manage payroll, pay taxes, or handle large transactions entirely in cash. It's not just inconvenient; it's dangerous and inefficient. Some Cannabis businesses have managed to secure limited banking services through state-chartered banks or credit unions willing to take on the risk and compliance burden. However, these services often come with hefty fees and restrictions, making them less than ideal for growing businesses. The lack of banking access has broader implications beyond day-to-day operations. Without bank accounts, Cannabis businesses struggle to build credit histories, making it nearly impossible to secure loans or lines of credit for expansion. This has forced many to rely on private investors or alternative funding sources, often at much higher interest rates than traditional business loans. Rescheduling Cannabis to Schedule III would fundamentally alter this landscape. While it wouldn't automatically solve all banking issues overnight, it would significantly reduce the perceived risk for financial institutions. Here's what we might expect: - *Increased Participation from Banks: *More banks, including larger national institutions, would likely begin offering services to Cannabis businesses. This increased competition could lead to better service offerings and reduced fees. - *Normalization of Financial Services:* Cannabis businesses could expect access to the full suite of financial services other industries take for granted. This includes business checking and savings accounts, merchant services for credit card processing, and payroll services. - *Electronic Payment Solutions:* With banking restrictions eased, we could see a proliferation of electronic payment solutions tailored for the Cannabis industry. This would reduce cash handling, improve security, and enhance the customer experience. - *Access to Capital Markets:* Improved banking relationships could pave the way for Cannabis businesses to access capital markets more easily. This could include everything from business loans and lines of credit to the ability to issue corporate bonds. - *Reduced Compliance Burden:* While compliance will always be a crucial aspect of Cannabis banking, rescheduling could simplify the reporting requirements for banks. This could make Cannabis accounts less costly to maintain, potentially reducing fees for businesses. - *Interstate Banking: *As the industry moves towards interstate commerce, having banking partners that can operate across state lines will become crucial. Rescheduling could make it easier for national banks to serve multi-state operators. However, it's important to note that challenges will remain. Banks will still need to comply with anti-money laundering laws and know-your-customer regulations. Cannabis businesses will need to maintain meticulous records and demonstrate full regulatory compliance to maintain their banking relationships. As accountants and financial professionals, our role in this new banking landscape will be critical. We'll need to help our clients navigate the transition from cash-based operations to full banking integration, ensuring they have the systems and controls in place to meet banks' requirements. Additionally, we'll play a key role in helping Cannabis businesses leverage their new banking relationships to fuel growth and improve operational efficiency. The shift in banking access represents a monumental change for the Cannabis industry. It's not just about having a place to deposit cash; it's about gaining access to the full spectrum of financial tools that can help these businesses scale, innovate, and compete in an increasingly sophisticated market. *Bankruptcy Protection: A Crucial Safety Net* Currently, Cannabis businesses operate in a precarious financial environment due to their inability to access bankruptcy protection. This is a direct result of Cannabis being classified as a Schedule I substance at the federal level. Let me illustrate why this is so significant. I've seen this impact firsthand. One of the first Cannabis farms I worked with went under, and the consequences were dire. Without the option of bankruptcy protection, there was no structured way to manage the business's decline. The result? A sudden closure that left many people jobless overnight. It's a scenario that plays out all too often in our industry, and it's one of the hidden risks that many don't consider when entering the Cannabis market. Rescheduling Cannabis to Schedule III could change this landscape dramatically. Here's what it might mean: 1. *Access to Chapter 11:* Cannabis businesses could gain the ability to file for Chapter 11 bankruptcy protection. This isn't about escaping debts; it's about providing a structured process for reorganization. It gives struggling businesses a chance to restructure their debts, renegotiate contracts, and potentially emerge as viable entities. 2. *Job Preservation:* With the option to reorganize rather than abruptly close, many jobs could be saved. In an industry that's becoming a significant employer in many states, this is crucial for local economies. 3. *Orderly Asset Distribution:* In cases where a business can't be saved, bankruptcy protection ensures a fair and orderly distribution of assets among creditors. This is far preferable to the current situation where the process can be chaotic and inequitable. 4. *Increased Investor Confidence:* The availability of bankruptcy protection could actually encourage more investment in the industry. Investors may be more willing to take risks if they know there's a structured process in place should things go wrong. 5. *Better Long-term Planning:* Cannabis businesses will be able to engage in more robust long-term planning, knowing they have this financial safety net if needed. It's important to note that while bankruptcy protection can be a lifeline, it's not a get-out-of-jail-free card. Businesses will still need to operate responsibly and maintain strong financial controls. As accountants and financial advisors, our role will be to help Cannabis businesses stay financially healthy and to guide them through the bankruptcy process if it becomes necessary. The introduction of bankruptcy protection to the Cannabis industry represents more than just a financial tool – it's a step towards normalizing Cannabis businesses in the eyes of the law and the financial sector. It's another piece of the puzzle in creating a stable, sustainable Cannabis industry that can weather economic ups and downs like any other sector. *Interested in Offering World-Class Accounting Services to the Cannabis Industry? * The Cannabis industry needs trained accountants now more than ever, to help them with compliance and maintaining a profitable, healthy business. We’ll teach you how to provide CFO-level support to growing companies in one of the fastest-growing industries in our generation. Click here to learn more. *Interstate Commerce: Breaking Down State Barriers* One of the most significant changes that rescheduling could bring to the Cannabis industry is the possibility of interstate commerce. This shift has the potential to completely reshape the market landscape. Let me break down what this could mean for the industry. *Current state of affairs * Right now, we essentially have 44 different state markets with varying pricing structures for similar products. It's a fragmented system that leads to inefficiencies and missed opportunities. For example, if you create an exceptional THC-infused kombucha in Oregon, you're limited to selling it within state lines. You can't ship it to Illinois, Oklahoma, or any other state, regardless of demand. This restriction limits growth potential and forces businesses to duplicate efforts across multiple states. *Opening new markets * Imagine a scenario where you could produce Cannabis products in one state and sell them across the entire country. This would allow businesses to: 1. Expand their customer base exponentially 2. Take advantage of economies of scale in production 3. Specialize in products that may have national appeal but limited local demand 4. Reduce costs by centralizing production in areas with optimal growing conditions or lower operating costs For instance, a California edibles manufacturer could suddenly access markets in Florida, New York, and everywhere in between. This opens up enormous growth potential for businesses that are currently constrained by state boundaries. *Challenges of state protectionism * However, it's not going to be a simple free-for-all. We need to be prepared for some pushback and complications: 1. *State-Level Protections:* States that have invested heavily in building up their local Cannabis industries may implement measures to protect these businesses from out-of-state competition. This could manifest as additional taxes on imported Cannabis products or licensing requirements for out-of-state businesses. 2. *Regulatory Disparities:* Different states have varying regulations on things like pesticide use, testing requirements, and product formulations. Navigating these differences for interstate sales will be complex. 3. *Tax Implications:* The current tax structures are based on intrastate commerce. Interstate sales will require new frameworks for how taxes are collected and distributed. 4. *Transportation Challenges:* Transporting Cannabis across state lines will require new security measures and tracking systems to prevent diversion to the black market. *Comparison to Other Industries * We might see a system develop similar to what we have with alcohol distribution. After Prohibition, many states implemented a three-tier system for alcohol sales, and we could see something similar emerge for Cannabis. This could involve separate licenses for producers, distributors, and retailers, with specific rules governing how products move between these tiers across state lines. *Implications for businesses and accountants * For Cannabis businesses, this shift will require: 1. Reevaluating business models and growth strategies 2. Investing in logistics and distribution networks 3. Navigating a more complex regulatory environment As accountants and financial advisors, we'll need to help our clients: 1. Understand the tax implications of selling across state lines 2. Develop systems for tracking multi-state sales and compliance 3. Evaluate opportunities for expansion or partnerships in new markets 4. Manage the increased complexity in financial reporting and auditing The move to interstate commerce represents both a massive opportunity and a significant challenge for the Cannabis industry. It has the potential to create national brands, drive down costs for consumers, and fuel rapid industry growth. However, it will also increase complexity and competition. Businesses that are prepared for this shift – with robust financial systems, clear strategies, and expert advice – will be best positioned to thrive in this new landscape. *Research and Development: Unleashing Innovation* Rescheduling Cannabis to Schedule III has the potential to dramatically accelerate research and development in the industry. This shift could unlock a new era of innovation, bringing together the worlds of Cannabis, pharmaceuticals, and biotechnology. Big pharma's entry into Cannabis One of the most significant changes we're likely to see is the entry of major pharmaceutical companies into the Cannabis space. These companies have been watching from the sidelines, hesitant to engage with a Schedule I substance. With rescheduling, we can expect them to dive in headfirst, bringing with them: 1. *Substantial R&D Budgets:* Pharmaceutical giants have deep pockets for research, potentially dwarfing current Cannabis R&D spending. 2. *Advanced Research Facilities:* Access to state-of-the-art labs and research tools could accelerate discoveries. 3. *Experienced Research Teams:* Scientists with expertise in drug development could bring new perspectives to Cannabis research. *Explosion of New Medicines and Products * This influx of resources and expertise could lead to a boom in new Cannabis-based medicines and products: 1. *Targeted Therapies:* We might see medications developed for specific conditions, moving beyond the current broad-spectrum approach of many Cannabis products. 2. *New Delivery Systems:* Research could yield innovative ways to administer cannabinoids, improving efficacy and patient experience. 3. *Isolating New Compounds:* Beyond THC and CBD, there are hundreds of cannabinoids and terpenes to explore. R&D could unlock the potential of these lesser-known compounds. 4. *Combination Therapies:* We might see Cannabis compounds combined with traditional pharmaceuticals for enhanced effects. Standardization and Quality Control Increased R&D is likely to lead to more standardized products: 1. *Consistent Dosing:* Pharmaceutical-grade products could offer more precise and reliable dosing. 2. *Quality Assurance:* Stricter manufacturing standards could improve product safety and consistency. 3. *Clinical Trials:* More robust clinical trials could provide stronger evidence for Cannabis's medical benefits. *Impact on the Industry * This R&D boom will have far-reaching effects: 1. Intellectual Property: We're likely to see a surge in Cannabis-related patents and proprietary formulations. 2. Job Creation: Increased R&D will create new jobs for scientists, researchers, and support staff. 3. Investment Opportunities: Companies with strong R&D pipelines could become attractive investment targets. *Challenges and Considerations * However, this shift also brings challenges: 1. Regulatory Navigation: Researchers will need to navigate FDA approval processes, which can be lengthy and costly. 2. Balancing Act: The industry will need to balance pharmaceutical development with the needs of existing medical Cannabis patients. 3. Small Players vs. Big Pharma: Smaller Cannabis companies might struggle to compete with the resources of large pharmaceutical corporations. *Implications for Cannabis Professionals * For those of us working in Cannabis finance and accounting, this R&D boom means: 1. New Valuation Metrics: We'll need to consider R&D pipelines and intellectual property in company valuations. 2. Complex Accounting: Tracking R&D expenses and capitalizing on successful developments will become crucial. 3. Funding Strategies: We'll need to help clients navigate funding options for costly R&D projects. 4. Tax Implications: Understanding R&D tax credits and how they apply to Cannabis businesses will be essential. The potential for R&D in a post-rescheduling Cannabis industry is enormous. It promises to transform not just the products available, but the entire landscape of the industry. As financial professionals, we need to be prepared to guide our clients through this new terrain, helping them capitalize on opportunities while navigating the complexities that come with increased research and development. *Regulatory Landscape: Navigating New Waters* Rescheduling Cannabis to Schedule III will significantly alter the regulatory landscape, but it won't simplify it entirely. In fact, we're likely to see a more complex, multi-layered regulatory environment emerge. Here's what we can expect: *Continued state-level regulation* Despite federal rescheduling, states will retain a significant role in Cannabis regulation: 1. Licensing: States will likely continue to control who can grow, process, and sell Cannabis within their borders. 2. Local Control: Many states allow municipalities to ban or restrict Cannabis businesses, a practice that's likely to continue. 3. State-Specific Rules: Expect continued variation in things like possession limits, home cultivation rights, and public consumption laws. This means Cannabis businesses will still need to navigate a patchwork of state regulations, especially if operating across multiple jurisdictions. *Federal oversight expansion * Rescheduling will bring increased federal involvement, primarily through agencies like the FDA and USDA: 1. FDA Oversight: The Food and Drug Administration will likely play a larger role in regulating Cannabis products, especially those making health claims. This could include: - Product safety standards - Labeling requirements - Marketing restrictions - Clinical trial oversight for medical claims 2. USDA Involvement: The U.S. Department of Agriculture may become more involved in setting standards for Cannabis cultivation, potentially including: - Organic certification processes - Pesticide use guidelines - Crop insurance programs 3. Federal Quality Standards: We might see the development of federal Good Manufacturing Practices (GMP) specific to Cannabis, similar to those in the pharmaceutical industry. Taxation Changes The regulatory shift will likely bring changes to the tax landscape: 1. 280E Reform: With Cannabis off Schedule I, we could see the end of 280E's application to Cannabis businesses, allowing for normal business deductions. 2. New Federal Taxes: However, don't be surprised if new federal excise taxes are introduced, similar to those on alcohol and tobacco. 3. State Tax Adjustments: States may need to adjust their tax structures in response to federal changes and to remain competitive with neighboring states. *Banking and financial services regulations * As banking opens up to the Cannabis industry, we'll see new regulatory frameworks emerge: 1. FinCEN Guidelines: Expect updated guidelines from the Financial Crimes Enforcement Network on how banks should work with Cannabis businesses. 2. Federal Reserve Policies: The Federal Reserve may need to create new policies for Cannabis banking, potentially including special reporting requirements. *Consumer Protection * With Cannabis becoming more mainstream, expect an increased focus on consumer protection: 1. Age Restrictions: Federal guidelines on age restrictions for Cannabis purchases may be implemented. 2. Product Testing: More rigorous and standardized testing requirements for potency, contaminants, and consistency. 3. Advertising Restrictions: Similar to tobacco, we might see federal restrictions on how Cannabis products can be advertised. *Environmental Regulations * The Cannabis industry's environmental impact will likely face increased scrutiny: 1. Energy Use: Regulations on energy consumption for indoor growing operations. 2. Water Usage: Guidelines on water use and runoff, especially in drought-prone areas. 3. Packaging Waste: Potential regulations on packaging materials and recycling requirements. *Implications for Cannabis Businesses and Financial Professionals * This evolving regulatory landscape will have significant implications: 1. Compliance Costs: Businesses will need to invest in robust compliance systems to navigate federal and state regulations. 2. Interstate Commerce Complexities: As discussed earlier, regulations around interstate Cannabis commerce will add new layers of complexity. 3. Increased Need for Expertise: Cannabis businesses will rely heavily on legal and financial professionals to navigate this new regulatory environment. 4. Reporting and Auditing: More complex regulations will require more sophisticated financial reporting and auditing processes. As accountants and financial advisors in the Cannabis space, we'll need to: - Stay up-to-date with rapidly changing regulations at both state and federal levels. - Help clients implement systems to ensure compliance across multiple regulatory frameworks. - Advise on the financial implications of new regulations, including tax changes and compliance costs. - Assist in preparing financial statements that meet new federal standards while still addressing state-specific requirements. The post-rescheduling regulatory landscape for Cannabis will be complex and dynamic. While it may resolve some current issues, it will undoubtedly create new challenges. Our role as financial professionals will be crucial in helping Cannabis businesses not just comply with these new regulations, but thrive within them. *Investors, Valuations, and Due Diligence: A New Era of Scrutiny* The rescheduling of Cannabis is set to dramatically alter the investment landscape. Let's dive into what this means for investors, company valuations, and the level of due diligence we can expect to see. *Investor landscape evolution * In the early days of the Cannabis industry, many investors got burned. They jumped in quickly, excited by the potential of this new market, without ensuring proper controls or good books were in place. The result? A lot of lost money and increased wariness among investors. Today's Cannabis investors are much more cautious and demanding. They're looking for businesses that can demonstrate: 1. Solid Financial Controls: Investors want to see that a company has robust systems in place to track and manage its finances accurately. 2. Compliance with Regulations: Given the complex regulatory environment, investors need assurance that businesses are operating within the law. 3. Strong Governance: Clear leadership structures and decision-making processes are crucial. 4. Growth Potential: Investors are looking for businesses that can scale and adapt in this rapidly changing industry. *Perpetual Data Rooms: A New Standard * One of the key demands we're seeing from investors is the implementation of perpetual data rooms. These are digital repositories that contain all crucial business documents and are continuously updated. They include: - Permanent files like leases, insurance policies, and tax returns - Regularly updated financial statements - Bank statements and invoices - What we call a "permanent audit trail" Having a well-maintained perpetual data room signals to investors that a business is organized, transparent, and ready for scrutiny. It's becoming a standard expectation, even for pre-revenue companies. *Valuations: The 280E effect * The potential elimination of 280E (the tax code that prohibits standard business deductions for Cannabis companies) could have a massive impact on valuations. Here's why: 1. Increased Cash Flow: Without 280E, Cannabis businesses could see their cash flow increase by 15-40%, depending on their effective tax rate and location. 2. Higher Net Income: The ability to deduct standard business expenses will significantly boost net income figures. 3. Multiplier Effect: These improvements in financial performance could lead to valuation increases of 5-10x almost overnight. For perspective, imagine a dispensary currently valued at $2 million. If 280E goes away, that same dispensary could potentially be worth $16 million. That's a game-changing increase for owners and investors. *Enhanced due diligence * With higher stakes and more institutional investors potentially entering the market, we can expect to see a much more rigorous due diligence process. This will likely include: 1. *Detailed Financial Audits:* Investors will want to see clean, accurate financial statements that can withstand scrutiny. 2. *Compliance Checks:* Thorough reviews of all licenses, permits, and adherence to state and local regulations. 3. *Operational Assessments:* Deep dives into business operations, supply chains, and growth strategies. 4. *Management Team Evaluation:* Close examination of the experience and track record of key personnel. 5. *Market Analysis:* Detailed assessment of the company's position in the market and growth potential. *Implications for Cannabis businesses * To attract investment and maximize valuations in this new landscape, Cannabis businesses need to: 1. *Implement Robust Financial Systems:* This includes detailed record-keeping, regular financial reporting, and strong internal controls. 2. *Maintain Impeccable Compliance:* Given the industry's regulatory complexities, businesses must be able to demonstrate strict adherence to all applicable laws. 3. *Develop Clear Growth Strategies:* Investors will be looking for well-thought-out plans for scaling and expanding the business. 4. *Build Strong Management Teams:* Having experienced, credible leadership will be crucial for attracting investment. 5. *Prepare for Scrutiny:* Businesses should be ready for a level of due diligence that may be more intense than they've experienced before. *The role of Cannabis Accounting Professionals * As accountants and financial advisors in the Cannabis industry, our role becomes even more critical in this evolving landscape. We need to: 1. Help clients build and maintain those all-important perpetual data rooms. 2. Ensure financial statements are audit-ready at all times. 3. Assist in developing financial models that can withstand investor scrutiny. 4. Guide clients through the complexities of valuation in a post-280E world. 5. Prepare clients for the level of due diligence they can expect from sophisticated investors. Our DOPE CFO Certified Advisors have helped clients raise over $10 million in cash. We know what investors and banks are looking for, and have access to several funding sources that are ready to provide capital. Give your clients the full suite of CFO services that they deserve by becoming a DOPE CFO Certified Advisor today. Click here to learn more. The rescheduling of Cannabis represents a massive opportunity for the industry, potentially unleashing a flood of new investment. However, it also means Cannabis businesses will be held to higher standards than ever before. Those that are prepared – with clean books, strong compliance, and clear growth strategies – will be best positioned to attract investment and achieve favorable valuations in this new era. *Descheduling vs Rescheduling * It’s also important to note that descheduling is different from rescheduling. Descheduling means you take it completely off the schedule. Ideally, that’s what we’ll see happen with Cannabis in the future. It's what happened with hemp and CBD back in 2018. If it comes off the schedules, then it could still be regulated by the state. For example, alcohol is not on schedules one to five and is regulated by the state, and can't be sold to minors. Different states have different laws. You know, in my home state of Oklahoma, you know, you couldn't drink craft brew during my years of growing up. Cannabis rescheduling will result in a lot of changes… But how will those changes affect accountants, bookkeepers, CPAs, and their clients? *How This Will Affect Accountants, Bookkeepers, CPAs, & Our Clients* The rescheduling of Cannabis will bring significant changes to the industry, and these changes will undoubtedly impact the work of accountants, bookkeepers, and CPAs serving Cannabis clients. The good news is that the fundamental principles of GAAP accounting will remain the same. This means that the core accounting practices you've honed will still be applicable, even as the industry undergoes transformation. *Accounting Changes* *280E and complex returns* The good news for us is - whether it's a farm, a processing plant, a manufacturer, a distributor, or a retailer - GAAP accounting is the same. It has nothing to do with the tax code and will remain complex and difficult to navigate. There will still be a need for cost accounting and the industry will still be multi-vertical. Just like every other complex niche in the US that is fully legal, like oil and gas or e-commerce or software, Cannabis will need niche experts to support their accounting. We’re likely to see lots of startups, cap raises, M&A, and exits as restrictions on the industry loosen. Things will heat up really quickly when rescheduling happens. Preparing taxes for Cannabis businesses is set to become more complex with rescheduling. Currently, due to IRC Section 280E, Cannabis businesses can't deduct most ordinary business expenses on their federal tax returns. However, they can include costs directly related to producing or acquiring their product as Cost of Goods Sold (COGS). Determining COGS for Cannabis businesses is already complicated. We must use GAAP cost accounting principles, specifically the rules under IRC Section 471, to calculate COGS accurately. This is crucial because COGS is considered a reduction of gross receipts rather than a deduction, allowing Cannabis businesses to recover some costs despite 280E restrictions. If Cannabis is rescheduled and 280E no longer applies, tax returns will likely become even more intricate. Businesses will need to navigate standard corporate tax rules, including various deductions and credits that were previously unavailable to them. This shift will require a more comprehensive approach to tax planning and preparation, potentially increasing the complexity of Cannabis tax returns. *Rescheduling and the Accountant’s Impact on Cannabis Company Valuations* To illustrate the potential impact of rescheduling on Cannabis company valuations, let's look at some data from leading multi-state operators (MSOs) in the industry. This information, compiled by the Green Market Report, provides a snapshot of current valuations and helps us project how these might change if 280E restrictions are lifted. (Source: Green Market Report) The chart shows various financial metrics for major Cannabis companies, including Enterprise Value (EV) to EBITDA ratios. These ratios are crucial for understanding how the market values these companies relative to their earnings before interest, taxes, depreciation, and amortization. Currently, we see EV/EBITDA ratios for 2023 estimates ranging widely, from as low as 4.57x for Ascend Wellness to as high as 53.10x for Glass House Brands. This wide range reflects the current uncertainty and variability in the Cannabis market. However, if 280E restrictions are removed, we could see a significant boost to these companies' EBITDA figures. Industry analysts, including those at Cannabis Business Executive, suggest we could see valuation multiples increase by a factor of 5 to 10 times current levels. To put this into perspective, let's consider a hypothetical example. If a Cannabis dispensary is currently valued at $2 million, the elimination of 280E could potentially increase its value to $16 million - an 8x increase. This dramatic rise would be driven by the sudden ability to deduct ordinary business expenses, significantly improving profitability and cash flow. This potential for value creation is not just theoretical. It represents real opportunities for business owners, investors, and even employees in the Cannabis industry. It also underscores the critical importance of proper financial management and reporting in the sector. As accountants and financial advisors, our role in helping Cannabis businesses navigate this potential transition and maximize their valuations will be more crucial than ever. *Is it going to be Challenging for Cannabis CFOs?* The road ahead for Cannabis CFOs is undoubtedly challenging. Regardless of whether Cannabis is descheduled or rescheduled, the industry will remain highly complex. CFOs will need to navigate extensive compliance requirements, limitations in vendor services, and the integration of numerous Cannabis-specific software solutions. The industry's rapid growth and evolving regulatory landscape will further compound these challenges. However, these challenges also represent an exciting opportunity for growth and innovation. As the industry matures, we can expect to see the development of more sophisticated accounting tools and industry-specific guidance. The increasing demand for skilled professionals in Cannabis accounting and finance underscores the potential for a rewarding and impactful career in this field. Despite the complexities, the Cannabis industry presents a promising future. Even without federal rescheduling, the industry has experienced massive growth, with states like Ohio and Minnesota recently legalizing Cannabis. The potential for full legalization in Florida and continued growth in states like Michigan and Massachusetts further highlights the industry's upward trajectory. This growth translates into a wealth of opportunities for accountants, CFOs, and CPAs willing to embrace the challenges and complexities of this booming and exciting industry. Our nationally recognized Cannabis accounting program has seen a surge in students eager to tap into these opportunities, even in states where Cannabis remains illegal. This demonstrates the growing recognition of the potential for success in Cannabis accounting and finance, regardless of location. The evolving Cannabis landscape is ripe with possibilities, and those prepared to navigate its complexities will be well-positioned to thrive. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Michigan’s leading cannabis trade group has filed a lawsuit to challenge the new 24% wholesale tax recently signed into law by Gov. Gretchen Whitmer. The news was posted by MJBizDaily, a source for financial, legal, and cannabusiness news. < Back Legal battle brews over Michigan’s new marijuana tax Oct 8, 2025 Margaret Jackson MJbizDaily Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Michigan’s leading cannabis trade group filed a lawsuit challenging the new 24% wholesale tax Gov. Gretchen Whitmer recently signed into law. Legal battle brews over Michigan’s new marijuana tax is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The endocannabinoid system (ECS) is vital for mammalian health, regulating basic functions like sleep, appetite, mood, and immune response. A balanced ECS is crucial, as imbalance can lead to various health issues. While cannabis can optimize the ECS, five alternative ways to boost it include reducing alcohol intake, getting bodywork treatments (like massage and acupuncture), eating leafy greens (which contain beta-caryophyllene), consuming omega-3 fatty acids, and engaging in enjoyable exercise. < Back 5 Simple Ways to Boost Your Endocannabinoid System Without Cannabis Oct 15, 2025 Dragonfly de la Luz Cannabis Now Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Our bodies all have a network of cannabinoid receptors that is vital to the health of all mammals: the endocannabinoid system. The ECS is a vast network of chemical compounds and receptors (namely CB1 and CB2) that regulate our most basic functions – sleep, appetite, mood, the immune system, inflammatory response, aging and memory. Endocannabinoids even produce feelings of relaxation and euphoria similar to those which come from ingesting cannabis. Aside from regulating essential everyday functions, the ECS maintains the body’s homeostasis down to the cell level by reversing damage in whatever way necessary. In cancer patients, for instance, cancer cells can be programmed to kill themselves when endocannabinoid levels increase. [image: boosting endocannabinoid system with omega 3s leafy greens no alcohol exercize] But as with most things, balance within this system is key. An overly inhibited CB1 receptor may lead to moodiness, depression and a suppressed immune system. On the other hand, an over-activated CB1 can increase risk of psychoactivity, inflammation, diabetes, obesity and cardiovascular problems. One study found that a highly sensitive endocannabinoid system is linked to almost all chronic diseases. So, a balanced ECS is fundamental to good health. Consuming cannabis is one fun and easy way to optimize the ECS. But not everyone has the freedom to enjoy this medicinal plant. Here are our top five simple ways to boost the endocannabinoid system without the aid of marijuana. * Drink Less Alcohol* Martin Lee, director of Project CBD and author of “Smoke Signals: A Social History of Marijuana – Medical, Recreational and Scientific,” explained the problem with drinking: “Alcohol is a poison that causes an acute stress response upon occasional consumption, which, in turn, provokes a temporary uptick of endocannabinoid activity as a protective response against stress,” Lee said. He added that while occasional drinking probably wouldn’t harm the ECS, “chronic alcoholism has the opposite effect, resulting in a depletion of endocannabinoid tone due to the wear and tear of too much stress. A low endocannabinoid baseline level makes a person more vulnerable to disease.” * Get Bodywork Treatments* A study by Auckland’s Unitec Institute of Technology showed that levels of anandamide — a cannabinoid responsible for feelings of bliss and joy — more than doubled after patients received osteopathic manipulative medicine treatments. This therapy can take various forms, including chiropractic, physical therapy and massage. Even acupuncture has a positive effect on the endocannabinoid system, so there’s never been a better excuse to take a spa day. * Eat Leafy Greens* If smoking frosty greens is not an option, then eating leafy greens will suffice. Along with oregano and black pepper, leafy greens contain beta-caryophyllene, a terpene that activates the CB2 receptor and is believed to have high potential for combatting inflammatory conditions and autoimmune disorders. * Eat More Omega-3s* Omega-3 fatty acids are essential for a well functioning ECS. Some scientists say that without them, CB1 receptors may not form correctly, which could lead to “impaired emotional behavior.” While fish oils are widely considered one of the best sources of omega-3s, hemp is an excellent alternative. Whether in seed, oil or protein form, hemp’s omega-3s can help keep your ECS functioning properly. * Exercise * German researchers have shown that “runner’s high” is not actually caused by an endorphin rush, but instead is a result of an increase in endocannabinoid production. And running isn’t the only activity that produces this effect. Any exercise can lead to an increase in endocannabinoids, so long as the activity doesn’t feel forced. The body interprets forced exercise as a stressor, which can actually produce the opposite effect and decrease endocannabinoid receptor signaling. So, dust off the yoga mat, jump up and down on a trampoline or even go out dancing to maintain a healthy endocannabinoid system. *Originally published in the print edition of Cannabis Now.* *LEARN MORE* *TELL US, *how do you combine cannabis with other wellness techniques? The post 5 Simple Ways to Boost Your Endocannabinoid System Without Cannabis appeared first on Cannabis Now. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5